Guidelines on the use of extracorporeal photopheresis

BACKGROUND: After the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by the FDA for its refractory forms, the technology has shown significant promise in the treatment of othe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Eur Acad Dermatol Venereol
Hauptverfasser: Knobler, R, Berlin, G, Calzavara-Pinton, P, Greinix, H, Jaksch, P, Laroche, L, Ludvigsson, J, Quaglino, P, Reinisch, W, Scarisbrick, J, Schwarz, T, Wolf, P, Arenberger, P, Assaf, C, Bagot, M, Barr, M, Bohbot, A, Bruckner-Tuderman, L, Dreno, B, Enk, A, French, L, Gniadecki, R, Gollnick, H, Hertl, M, Jantschitsch, C, Jung, A, Just, U, Klemke, C-D, Lippert, U, Luger, T, Papadavid, E, Pehamberger, H, Ranki, A, Stadler, R, Sterry, W, Wolf, IH, Worm, M, Zic, J, Zouboulis, CC, Hillen, U
Format: Artigo
Sprache:Inglês
Veröffentlicht: BlackWell Publishing Ltd 2014
Schlagworte:
Guidelines on the Use of Extracorporeal Photopheresis. Publication of This Supplement was Supported by a Grant From the European Dermatology Forum
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4291097/
https://ncbi.nlm.nih.gov/pubmed/24354653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.12311
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge